The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Tissue factor is a central and major player in the clotting process. It exists in both active and inactive forms. The active form initiates clot formation. How it gets activated is one of the most important unanswered questions in this area of research. Our aim is to discover tissue factorÍs mechanism of activation. The outcome will provide more specific targets for therapeutic drug development for cardiovascular disease, strokes and deep venous thrombosis.
Osteoporotic Fracture-Mortality Association And The Effect Of Anti-osteoporosis Treatment: A Multinational Study
Funder
National Health and Medical Research Council
Funding Amount
$84,800.00
Summary
Osteoporosis burden is due primarily to osteoporotic fractures resulting in economic and public health burden, increased disability, further fracture risk and more importantly early death. However, it remains under-treated although treatment reduces the number of fractures and may reduce early death. This study aims to understand which types of fractures result in early death and for which age groups and whether osteoporosis treatment does or does not reduce early death.
Predicting Infections In Cancer Of The Plasma Cells In Bone Marrow (myeloma)
Funder
National Health and Medical Research Council
Funding Amount
$107,764.00
Summary
The study will look for new risks for infection in patients with multiple myeloma, a cancer of plasma cells in the bone marrow. Currently these patients are expected to live longer because of the discovery and use of new generation cancer drugs. By finding new infection risks, the treatment of life threatening infections can be improved or infection can be prevented so patients have a better quality of life whilst on cancer treatment.
Investigating The Impact Of Ethnicity On Asthma: Determining Risk Factors, Modifiers, Clinical Phenotypes, And Differential Response To Treatment.
Funder
National Health and Medical Research Council
Funding Amount
$125,396.00
Summary
Asthma is a common disease in Australia with significant burden on both patients and the public healthcare system. Patients from ethnic minorities have disproportionately worse outcomes and current treatment guidelines are based on research among Caucasian-based populations. My PhD will describe differences in clinical characteristics, outcomes and response to treatment between ethnic groups. The overall aim of my PhD is to develop highly effective asthma treatment for ethnic minorities.
Transcriptional Control Of Peripheral T Cell Differentiation During Pathogen Infection And Autoimmunity
Funder
National Health and Medical Research Council
Funding Amount
$92,314.00
Summary
White blood cells, specifically helper and killer T cells, play an important role in fighting infection. They are tightly regulated and if not properly controlled can lead to aggressive autoimmune diseases such as diabetes and multiple sclerosis. My studies will elucidate the mechanisms behind the regulation of T cells at steady-state and during disease. Insights gained from this project will have implications for the design of new approaches to combat infectious and autoimmune diseases.
The assessment of thrombosis requires the holistic evaluation of in-vivo coagulation including total clot formation. Unfortunately, current tests only evaluate the time to the start of clot formation. Experimental biomarkers such us thrombin generation, endothelial markers, microparticles and microRNA may provide a better framework for evaluating thrombotic risk. Translation of these markers to clinical use requires understanding of their expression in the normal population and assessment of the ....The assessment of thrombosis requires the holistic evaluation of in-vivo coagulation including total clot formation. Unfortunately, current tests only evaluate the time to the start of clot formation. Experimental biomarkers such us thrombin generation, endothelial markers, microparticles and microRNA may provide a better framework for evaluating thrombotic risk. Translation of these markers to clinical use requires understanding of their expression in the normal population and assessment of their ability to detect thrombotic disorders.Read moreRead less
Better Data To Inform Interventions To Reduce The Risk Of Stillbirth In Australia
Funder
National Health and Medical Research Council
Funding Amount
$75,830.00
Summary
Stillbirth is a devastating experience for parents and families. Paucity of high quality data on causes and contributing factors is a major barrier to the development of research priorities and interventions to prevent stillbirths and improve the quality of care. This research will be a connected body of work that aims to better describe the epidemiology of stillbirth in Australia, contribute to the classification of stillbirths and determine the needs of parents in relation to autopsy consent.
Pre-eclampsia is a serious medical condition affecting 5% of pregnancies and resulting in significant mortality and morbidity for mothers and babies. As yet there is no acceptable test capable of detecting pre-eclampsia in early pregnancy and diagnosis is made when symptoms and signs are manifest and management options are limited to early delivery. This project is designed to assess the ability of a blood screening test to detect pre-eclampsia in early pregnancy to enable for early intervention ....Pre-eclampsia is a serious medical condition affecting 5% of pregnancies and resulting in significant mortality and morbidity for mothers and babies. As yet there is no acceptable test capable of detecting pre-eclampsia in early pregnancy and diagnosis is made when symptoms and signs are manifest and management options are limited to early delivery. This project is designed to assess the ability of a blood screening test to detect pre-eclampsia in early pregnancy to enable for early interventions and preventative management to be implemented.Read moreRead less
Determinants Of Cardiovascular Health Over The Lifecourse In A Population-based Cohort Study Of Australian Families
Funder
National Health and Medical Research Council
Funding Amount
$92,161.00
Summary
This unique project will examine the heart health of roughly 3500 11-12 year olds in Australia's only nationally-representative children's study. It will then examine factors that may contribute to differing heart disease progression. We will characterise established factors (such as cholesterol, blood pressure and diabetes), as well as measures of infection burden and inflammation to examine the innovative theory that childhood infection and/or its treatment contribute to poorer heart health.